Clinical trials · Philadelphia, PA
Medulloblastoma Recurrent clinical trials in Philadelphia
We’re tracking 3 recruiting medulloblastoma recurrent studies with a site in or near Philadelphia — including Phase 1/Phase 2 and Phase 2 studies, each written for real people, not researchers.
Recruiting studies near Philadelphia
- NCT05057702Recruiting
Personalized surgery-focused treatment plan for relapsed brain cancer
This study tests a personalized treatment plan for children and young adults whose medulloblastoma or ependymoma has come back. It aims to guide doctors using new tissue from surgery or biopsy after earlier treatments are fully finished.
Philadelphia, PennsylvaniaAges 1–39 - NCT05096481RecruitingPhase 2
Vaccine for brain tumors in children and young adults
This trial tests a vaccine that may help the immune system fight brain tumors (medulloblastoma, high-grade glioma, and DIPG). It is for patients who have already had standard treatment and whose tumors are still present or have returned.
Philadelphia, PennsylvaniaAges 3–39 - NCT05278208RecruitingPhase 1/Phase 2
Lutathera for high-grade brain tumors that returned or got worse
This trial tests if Lutathera, a radioactive drug that targets certain tumors, can help children and young adults with high-grade brain tumors or meningiomas that have come back or are growing. It aims to see if the treatment is safe and works.
Philadelphia, PennsylvaniaAges 4–39
Hear when a new Medulloblastoma Recurrent trial opens near Philadelphia, PA
We’ll email you when one opens near Philadelphia, PA — at most once a week, no account needed, unsubscribe anytime.
Medulloblastoma Recurrent trials in other cities
Where these studies are running near Philadelphia
Institutions with a site for the recruiting medulloblastoma recurrent studies listed above.
- Children's Hospital of Philadelphia · 3 studies
What taking part in a medulloblastoma recurrent study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting medulloblastoma recurrent studies in Pennsylvania.
Common questions
- Are there medulloblastoma recurrent clinical trials near Philadelphia?
- Yes. We're currently tracking 3 recruiting medulloblastoma recurrent studies with a site near Philadelphia, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a medulloblastoma recurrent study near Philadelphia?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Philadelphia to take part?
- Not necessarily. These studies have a site near Philadelphia, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a medulloblastoma recurrent trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New medulloblastoma recurrent studies open near Philadelphia regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.